| Filed On | Filing |
|---|---|
| 16 Oct 2026 |
Form 4: Kreitzer Anatol, Chief Discovery Officer
Sold 12,248 shares ($96K) |
| 16 Oct 2026 |
Form 4: Foff Erin Pennock, Chief Medical Officer
Sold 15,355 shares ($124K) |
| 16 Oct 2026 |
Form 4: Hanson Kristopher, General Counsel
Sold 9,020 shares ($72.9K) |
| 16 Oct 2026 |
Form 4: Lillie James Woodruff, Chief Scientific Officer
Sold 11,513 shares ($93K) |
| 16 Oct 2026 |
Form 4: Gillis Jonathan, CAO and Interim CFO
Sold 10,167 shares ($82.1K) |
| 16 Oct 2026 |
Form 4: Kroeger Christopher A., Director
Sold 73,691 shares ($595K) |
| 18 Sep 2026 |
Form 4: Hanson Kristopher, General Counsel
Sold 16,509 shares ($193K) |
| 19 Aug 2026 |
Form 4: Kreitzer Anatol, Chief Discovery Officer
Received 6,020 shares as a grant or award · Granted 24,455 Employee Stock Option (right to buy) |
| 19 Aug 2026 |
Form 4: Gillis Jonathan, CAO and Interim CFO
Received 8,242 shares as a grant or award · Granted 24,455 Employee Stock Option (right to buy) · Granted 2,813 Employee Stock Option (Right to Buy) |
| 19 Aug 2026 |
Form 4: Lillie James Woodruff, Chief Scientific Officer
Received 7,730 shares as a grant or award · Granted 31,395 Employee Stock Option (right to buy) |
| 19 Aug 2026 |
Form 4: Hanson Kristopher, General Counsel
Received 7,730 shares as a grant or award · Granted 31,395 Employee Stock Option (right to buy) |
| 19 Aug 2026 |
Form 4: Foff Erin Pennock, Chief Medical Officer
Received 13,360 shares as a grant or award · Granted 54,240 Employee Stock Option (right to buy) |
| 19 Aug 2026 |
Form 4: Kroeger Christopher A., Director
Received 23,145 shares as a grant or award · Granted 93,955 Employee Stock Option (right to buy) |
| 18 Aug 2026 |
Form 4: Catalyst4, Inc., 10% owner
Bought 4,400,000 shares ($50.1M) · Acquired 2,928,686 Warrants (right to buy) (Open Market Purchase) ($33.3M) |
| 04 Aug 2026 |
Form 4: Lillie James Woodruff, Chief Scientific Officer
Sold 22,082 shares ($277K) |
| 30 Jul 2026 |
Form 4: Catalyst4, Inc., 10% owner
Bought 206,225 shares ($2.28M) · Bought 3,000 shares ($37.9K) · Bought 1,000,000 shares ($13M) |
| 28 Jul 2026 |
Form 4: Cox Troy, Director
Bought 15,620 shares ($149K) |
| 20 Jul 2026 |
Form 4: Kreitzer Anatol, Chief Discovery Officer
Sold 10,055 shares ($367K) · Sold 9,056 shares ($333K) · Sold 17,173 shares ($646K) |
| 20 Jul 2026 |
Form 4: Gillis Jonathan, CAO and Interim CFO
Sold 10,055 shares ($367K) · Sold 8,455 shares ($311K) · Sold 18,469 shares ($694K) |
| 17 Jul 2026 |
Form 4: Kroeger Christopher A., Director
Sold 61,778 shares ($2.27M) · Sold 69,082 shares ($2.54M) · Sold 16,779 shares ($636K) |
Loading...